Simultaneous TLC-densitometric determination of tamoxifen citrate and medroxyprogesterone acetate and UV-degradation kinetic study of medroxyprogesterone acetate

Simultaneous Determination of Estradiol Cypionate and Medroxyprogesterone Acetate Hormones in Injectable Suspension by UV Spectrophotometry Based on Least-Squares Support Vector Machine and Fuzzy Inference System: Comparison with HPLC

BACKGROUND

The combination of estradiol cypionate (ECA) and medroxyprogesterone acetate (MPA) is used to prevent pregnancy in women. The analysis of the ECA and MPA combination reveals a challenge due to the strong overlap of the spectra of these compounds.

OBJECTIVE

Spectrophotometry techniques along with chemometrics methods are simple, fast, precise, and low-cost for the simultaneous determination of ECA and MPA in a combined pharmaceutical dosage form.

METHODS

Two developed approaches, the least-squares support vector machine (LSSVM) and fuzzy inference system (FIS), along with a spectrophotometric method were proposed to solve such a challenging overlap.

RESULTS

Based on the cross-validation method, the regularization parameter (γ) and width of the function (σ) in the LSSVM model were optimized and the root mean square error (RMSE) values were found to be 0.3957 and 0.2839 for ECA and MDA, respectively. The mean recovery values were 99.87 and 99.63% for ECA and MDA, respectively. The FIS coupled with principal component analysis (PCA) showed mean recovery percentages equal to 99.05 and 99.50% for ECA and MDA, respectively. Also, the RMSE of both components was lower than 0.3.

CONCLUSION

The analysis results of a real sample (injection suspension) using the proposed methods were compared with HPLC by a one-way analysis of variance (ANOVA) test, and no significant differences were found in the results.

HIGHLIGHTS

Intelligent methods were proposed for the simultaneous determination of ECA and MPA. The least-squares support vector machine and fuzzy inference system along with spectrophotometry were used. HPLC as a reference method was performed and compared with chemometrics methods. The benefits of the proposed approaches are that they are rapid, simple, low-cost, and accurate.

Cyclic and Linear Sweep Voltammetric Studies of a Modified Carbon Paste Electrode with Nickel Oxide Nanoparticles toward Tamoxifen: Effects of Surface Modification on Electrode Response Kinetics

Due to the serious adverse futures of some anticancer drugs, the determination of trace amounts of these drugs by simple analytical techniques is of great interest. In this regard, knowing about the mechanism of the analyte with the sensing material plays an important role. Nickel oxide nanoparticles (NiO NPs) modified by a carbon paste electrode (NiO-CPE) showed an irreversible cyclic voltammetric (CV) behavior in the NaOH (pH 13) supporting electrolyte based on the peak separation of 311 mV. Its peak current was decreased by adding tamoxifen (TAM), confirming that TAM molecules can consume NiO before participating in the electrode reaction. For this goal, TAM can be oxidized or reduced, and the corresponding mechanisms are schematically illustrated in the text. This study focused on the kinetic aspects of the process. Based on the CV results, a surface coverage (Γ) value of 2.72 × 10^-5 mol NiO per cm² was obtained with charge transfer coefficients α_a and α_c of 0.317 and 0.563, respectively. α_a and α_c values were changed to 0.08 and 0.72 in the presence of TAM. Further, the rate constant (k _s) value was 0.021 ± 0.01 s^-1 in the presence of TAM. In linear sweep voltammetry (LSV), an α value of about 0.636 ± 0.023 and an exchange rate constant (k _o) value of about 0.097 ± 0.031 s^-1 were obtained in the absence of TAM, which changed to 0.62 ± 0.081 and 0.089 ± 0.021 s^-1 in the presence of TAM, respectively. Despite more published papers, when the TAM analyte was added to the NaOH supporting electrolyte, both anodic and cathodic peak currents of the modified NiO-CPE decreased. We suggested some reasons for this decreased peak current, and four mechanisms were illustrated for the electrode response in the presence of TAM.

Analysis of tamoxifen and its main metabolites in plasma samples of breast cancer survivor female athletes: Multivariate and chemometric optimization

A sensitive method based on liquid chromatography combined with a diode array detector was developed and validated to simultaneously determine tamoxifen, and its active metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen, and endoxifen in human plasma samples. The green and sustainable vortex-assisted dispersive liquid-phase microextraction technique based on the natural hydrophobic deep eutectic solvent was used for the extraction and pre-concentration of the analytes. Chemometrics and multivariate analysis were used to optimize the independent variables, including the type and volume of deep eutectic solvent, extraction time, and ionic strength. Under optimal conditions, calibration curves were linear in a suitable range with the lower limits of quantification (0.8-10.0 μg L^-1 ), which covered the relevant concentrations of the analytes in plasma samples for a clinical study. Intra- and inter-day precision evaluated at three concentrations for the analytes were lower than 8.2 and 12.1 %, respectively. Accuracy was in the range of 94.9-104.7%. The applicability of the developed method on human plasma samples illustrated the range 45.1-72.8, 98.4-128.3, 0.9-1.2, and 2.7-6.1 μg L^-1 for tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen, and endoxifen, respectively. The validated method can be effective for the pharmacokinetics, pharmacodynamics, and therapeutic drug monitoring studies of tamoxifen and its main metabolites in biological fluids. This article is protected by copyright. All rights reserved.

Insights for applying erythrosine B as a green fluorescence probe for estimation of anticancer tamoxifen and its analog; clomiphene in nanogram concentration

The growth of tumor tissue is extremely pervasive among post-menopausal women. Commonly, from the clinical application, adjuvant selective estrogen receptor modulators such as tamoxifen are prescribed for prohibiting metastatic breast cancer, while its analog, clomiphene, is used to treat infertility in women. Lately, the significance of green chemistry on our environment was through reducing the influence of hazardous chemicals. Consequently, efforts were screened to perform a fast and simple eco-friendly green method for the determination of two aromatase inhibitors. In this study, a sensitive green spectrofluorimetric approach was developed to detect and characterize tamoxifen citrate (TAM) and clomiphene citrate (CLO) via complex formation with erythrosine B. The reaction between erythrosine B dye (EB) and the two aromatase inhibitors results in quenching the fluorescence activity of the dye by the formation of ion-pair in Britton-Robinson buffer (BRB) solution (pH 4.3) at 554 nm (λ_ex = 527 nm). The approach outcome confirmed that the solvent's inherent nature has a critical impact on the approachs' sensitivity and reproducibility. An approved linear correlation was achieved between the reduction in the emission value of EB's fluorescence and the concentration in the ranges of 40.0-600.0 ng/mL for both TAM and CLO with mean % recoveries 100.20 ± 0.93 and 100.07 ± 1.09, respectively. The approach was validated regarding ICH protocols, and the outcomes were acceptable. The changes in Gibb's free energy (ΔG°) by the obtained ion-pair between EB and TAM or CLO were -36.65 or -37.03 kJ mol^-1, respectively, which indicates the reaction feasibility at ambient temperature. Commercial dosage forms for TAM and CLO were simply analyzed, and good recoveries were achieved within the range. The National Environmental Methods Index, Analytical Eco-Scale, and Green Analytical Procedure Index applications to our illustrated approach present additional eligibility to this study.

Factorial approach for the optimization and development of stability indicating study of the contraceptive suspension for injection(Depo-Provera®)

The study involves use of factorial design for optimization of forced degradation conditions and development of stability indicating method for medroxyprogestrone acetate (MPA) or depo-provera as known in the market. MPA is an important contraceptive and anticancer drug especially for treatment of breast cancer and it is the first time to study the different conditions affecting its stability. MPA was subjected to different variables such as solvent type, pH and the time subjected to UV light. Factorial design has been used during forced degradation to determine significant factors responsible for degradation and to optimize degradation conditions reaching maximum degradation. Factors responsible for forced degradation were statistically evaluated using Bubble and Surface plots. Variables proved to be significant (p < 0.05) and the suggested model represented a perfect example for indicating the efficiency of factorial designs in optimizing the degradation conditions that give maximum percent of degradation. We investigated also the solubility and stability profiles of MPA in aqueous solutions. Stability study results showed a very low stability profile of MPA in all the aqueous solutions with rapid degradation rate more than other solvents. The current research may contribute to enrich the knowledge of the physicochemical properties of this drug for exploring its full anticancer potential in the future.